ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CD BioGlyco Released Advanced GlycoTM Synthesis Platform for Cyclodextrin Development Research

By: Get News
CD BioGlyco is excited to announce the launch of its multifunctional and advanced GlycoTM Synthesis Platform that can provide custom development of cyclodextrins to be used in food, pharmaceutical, agriculture, chemical, cosmetics, biotechnology industries.

New York, USA – September 29, 2022 – CD BioGlyco, a biotechnology company specialized in providing glycobiology-related products, analysis, custom synthesis, and design, is excited to announce the launch of its multifunctional and advanced GlycoTM Synthesis Platform that can provide custom development of cyclodextrins to be used in food, pharmaceutical, agriculture, chemical, cosmetics, biotechnology industries.

Because of their chemical adaptability, cyclodextrins can be modified to produce mono- or poly-substituted derivatives, which can enhance their solubility and stability as well as control how well they can form complexes. Significant modifications to the guest’s spectroscopic characteristics, reactivity, volatility, solubility, and stability result from the complexation process. They are also extensively utilized in the chemical, food, pharmaceutical, agricultural, and oilfield industries, as well as in the biotechnology and cosmetics sectors.

With a professional synthesis platform, CD BioGlyco’s highly skilled scientists can provide several strategies to prepare cyclodextrins-guest complexes including kneading, grinding, microwave irradiation, supercritical carbon dioxide, co-precipitation, and spray-dried.

Now, CD BioGlyco provides custom cyclodextrin development services including:

* Pharmaceutical Cyclodextrin Development

Preparation of sulfonated cyclodextrins, synthesis/production of cyclodextrins and their derivatives, etc.

* Non-Pharmaceutical Cyclodextrin Development

Provide cyclodextrins that can be used as food additives, applied in water purification and cyclodextrin powders that can be used for odor control, etc.

* Cyclodextrin Analysis Services

A variety of cyclodextrin analysis methods, such as NMR, HPLC, MS, IR, GC, etc.

Service Advantages

• Design, production, and analysis one-stop service

• Customized protocols for different synthesis needs

• High reliability and short test cycles

• Efficient, reliable and cost-effective

“We are committed to the development of pharmaceutical cyclodextrin to provide you with the most reliable products. And we can also provide highly-customized solutions based on your specific needs.” Said Anna, one of the representative speakers from CD BioGlyco.

To know more detailed information about the custom cyclodextrin development service provided by CD BioGlyco, please visit https://www.bioglyco.com/custom-cyclodextrin-development.html.

Media Contact
Company Name: CD BioGlyco
Contact Person: Anna
Email: Send Email
Phone: 1-631-749-6145
Country: United States
Website: https://www.bioglyco.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.